top of page

The economic footprint of the biopharmaceutical industry can be measured by traditional indicators of employment and output, and its impact on the vendors, large and small, that provide services or supplies to America's biopharmaceutical research companies. The data below illustrates jobs, economic impact and clinical trial data for the industry as a whole, and vendor/supplier data from 15 major biopharmaceutical companies regarding their business relationships and total expenditures paid to vendors in Washington, D.C. in 2022.

Economic
Output
$2.8B
Direct Jobs Supported by the Industry
3,809
Total Jobs Supported by the Industry
8,359
State Total Vendor Relationships
949
State Total Vendor Spending
$560,133,730
Clinical Trials
794
Clinical Trial Participants
674,458
bottom of page